Table 4.

Bivariate Results: Sociodemographic Characteristics That Are Statistically Significantly Correlated (p < .05) with Preferred Choice of HIV Control Strategy (United States, 2018)

	Preferred choice of strategy to control HIV (mutually exclusive)
Characteristic	Prefer current, daily pill version of HIV medication over all other options	Prefer long-acting injectable or implantable form of HIV medication that lasts for 1 month over all other options	Prefer long-acting injectable or implantable form of HIV medication that lasts for 2 months over all other options	Prefer long-acting injectable or implantable form of HIV medication that lasts for 6 months over all other options	Prefer new HIV remission strategy over all other options
Gender				Cis and trans women (OR = 2.01) more likely to prefer this strategy than cis men	Cis and trans women (OR = 0.46) less likely to prefer this strategy than cis men
Education				Doctorates (OR = 0.20) and 4-year college graduates (OR = 0.36) less likely to prefer this strategy than high-school graduates	Doctorates (OR = 8.75) and Masters (OR = 5.48) more likely to prefer this strategy than high-school graduates
Region				Midwesterners (OR = 6.02) more likely to prefer this strategy than Northeasterners
Household income	$25k–$50k group (OR = 0.07) less likely to prefer this strategy than <$15k group				$50k–$75k group (OR = 3.82) and >$100k group (OR = 3.47) more likely to prefer this strategy than <$15k group
Income source				People with a regular, part-time job (OR = 2.75) more likely to prefer this strategy than those without	People with a regular, full-time job (OR = 2.15) more likely to prefer this strategy than those without

Age, race, ethnicity, partnership status, financial status, time since first exposure to HIV, time living with HIV, and health status are not statistically significantly correlated with preferred choice of HIV control strategy.

OR, odds ratio.